PhaseV launches AI Enrollment Lab at SCOPE Summit, using real-world EHR data to quantify patient-level competition in trials.
Introduced during the SCOPE Summit, PhaseV has presented a virtual solution that utilizes genuine EHR data to assess patient-level competition and eligibility prior to protocol lock. The announcement was made in Boston on February 2, 2026. This innovative tool aims to enhance clinical development by leveraging AI/ML technology.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments